MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 117 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,055,580 | +27.3% | 65,050 | +4.2% | 0.38% | +34.6% |
| Q2 2023 | $1,614,547 | +8.2% | 62,410 | +0.5% | 0.28% | -13.8% |
| Q1 2023 | $1,492,074 | +45.0% | 62,118 | +17.8% | 0.32% | +18.6% |
| Q4 2022 | $1,028,703 | +15.5% | 52,754 | +24.4% | 0.27% | +8.3% |
| Q3 2022 | $891,000 | +43.0% | 42,395 | +32.4% | 0.25% | +10.5% |
| Q2 2022 | $623,000 | -6.7% | 32,014 | +5.5% | 0.23% | +17.4% |
| Q1 2022 | $668,000 | – | 30,354 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |